IBDEI2YT ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47322,1,4,0)
 ;;=4^J96.10
 ;;^UTILITY(U,$J,358.3,47322,2)
 ;;=^5008350
 ;;^UTILITY(U,$J,358.3,47323,0)
 ;;=J96.12^^181^2361^9
 ;;^UTILITY(U,$J,358.3,47323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47323,1,3,0)
 ;;=3^Resp Failure,Chronic w/ Hypercapnia
 ;;^UTILITY(U,$J,358.3,47323,1,4,0)
 ;;=4^J96.12
 ;;^UTILITY(U,$J,358.3,47323,2)
 ;;=^5008352
 ;;^UTILITY(U,$J,358.3,47324,0)
 ;;=J96.11^^181^2361^10
 ;;^UTILITY(U,$J,358.3,47324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47324,1,3,0)
 ;;=3^Resp Failure,Chronic w/ Hypoxia
 ;;^UTILITY(U,$J,358.3,47324,1,4,0)
 ;;=4^J96.11
 ;;^UTILITY(U,$J,358.3,47324,2)
 ;;=^5008351
 ;;^UTILITY(U,$J,358.3,47325,0)
 ;;=R06.03^^181^2361^3
 ;;^UTILITY(U,$J,358.3,47325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47325,1,3,0)
 ;;=3^Resp Distress,Acute
 ;;^UTILITY(U,$J,358.3,47325,1,4,0)
 ;;=4^R06.03
 ;;^UTILITY(U,$J,358.3,47325,2)
 ;;=^5151591
 ;;^UTILITY(U,$J,358.3,47326,0)
 ;;=S23.9XXA^^181^2362^20
 ;;^UTILITY(U,$J,358.3,47326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47326,1,3,0)
 ;;=3^Sprain Thorax,Unspec Part,Initial Encounter
 ;;^UTILITY(U,$J,358.3,47326,1,4,0)
 ;;=4^S23.9XXA
 ;;^UTILITY(U,$J,358.3,47326,2)
 ;;=^5023267
 ;;^UTILITY(U,$J,358.3,47327,0)
 ;;=I69.928^^181^2362^14
 ;;^UTILITY(U,$J,358.3,47327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47327,1,3,0)
 ;;=3^Speech/Lang Deficits Following Unspec Cerebrovascular Disease
 ;;^UTILITY(U,$J,358.3,47327,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,47327,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,47328,0)
 ;;=S13.4XXA^^181^2362^19
 ;;^UTILITY(U,$J,358.3,47328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47328,1,3,0)
 ;;=3^Sprain Ligaments Cervical Spine,Initial Encounter
 ;;^UTILITY(U,$J,358.3,47328,1,4,0)
 ;;=4^S13.4XXA
 ;;^UTILITY(U,$J,358.3,47328,2)
 ;;=^5022028
 ;;^UTILITY(U,$J,358.3,47329,0)
 ;;=M15.3^^181^2362^5
 ;;^UTILITY(U,$J,358.3,47329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47329,1,3,0)
 ;;=3^Secondary Multiple Arthritis
 ;;^UTILITY(U,$J,358.3,47329,1,4,0)
 ;;=4^M15.3
 ;;^UTILITY(U,$J,358.3,47329,2)
 ;;=^5010765
 ;;^UTILITY(U,$J,358.3,47330,0)
 ;;=L08.9^^181^2362^10
 ;;^UTILITY(U,$J,358.3,47330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47330,1,3,0)
 ;;=3^Skin Infection,Unspec
 ;;^UTILITY(U,$J,358.3,47330,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,47330,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,47331,0)
 ;;=L98.9^^181^2362^11
 ;;^UTILITY(U,$J,358.3,47331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47331,1,3,0)
 ;;=3^Skin/Subcutaneous Tissue Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,47331,1,4,0)
 ;;=4^L98.9
 ;;^UTILITY(U,$J,358.3,47331,2)
 ;;=^5009595
 ;;^UTILITY(U,$J,358.3,47332,0)
 ;;=R22.2^^181^2362^21
 ;;^UTILITY(U,$J,358.3,47332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47332,1,3,0)
 ;;=3^Swelling,Mass & Lump,Trunk
 ;;^UTILITY(U,$J,358.3,47332,1,4,0)
 ;;=4^R22.2
 ;;^UTILITY(U,$J,358.3,47332,2)
 ;;=^5019286
 ;;^UTILITY(U,$J,358.3,47333,0)
 ;;=M54.31^^181^2362^3
 ;;^UTILITY(U,$J,358.3,47333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47333,1,3,0)
 ;;=3^Sciatica,Right Side
 ;;^UTILITY(U,$J,358.3,47333,1,4,0)
 ;;=4^M54.31
 ;;^UTILITY(U,$J,358.3,47333,2)
 ;;=^5012306
 ;;^UTILITY(U,$J,358.3,47334,0)
 ;;=M54.32^^181^2362^2
 ;;^UTILITY(U,$J,358.3,47334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47334,1,3,0)
 ;;=3^Sciatica,Left Side
 ;;^UTILITY(U,$J,358.3,47334,1,4,0)
 ;;=4^M54.32
